Display options
Share it on

Metabolomics. 2009 Sep;5(3):363-374. doi: 10.1007/s11306-009-0161-7. Epub 2009 Apr 26.

omega-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids.

Metabolomics : Official journal of the Metabolomic Society

Gregor McCombie, Lucy M Browning, Christopher M Titman, Molly Song, John Shockcor, Susan A Jebb, Julian L Griffin

PMID: 20208976 PMCID: PMC2826632 DOI: 10.1007/s11306-009-0161-7

Abstract

Previous studies have shown that a combination of weight loss and fish oil supplementation reduce cardiovascular disease and diabetes risks by increasing adiponectin and reducing triacylglyceride concentrations, while weight loss alone significantly improves insulin sensitivity and reduces inflammation. Here, a metabolomic approach, using a combination of (1)H-Nuclear Magnetic Resonance spectroscopy, and gas and liquid chromatography and mass spectrometry, was employed to elucidate the metabolic changes in blood plasma following weight loss and fish oil supplementation. The intervention study was conducted over 24 weeks, with 93 female subjects randomised to one of three groups. Two groups followed a 12-week weight loss program, followed by a 12-week weight maintenance period and were randomised to fish or placebo oil capsules; a control group did not follow the weight loss program and were given placebo oil capsules. Lipid profiles changed dramatically upon fish oil intake and subtly across the two weight loss groups. While the fish oil supplementation increased the proportion of various phospholipid species, previously reported reductions in total triacylglycerides (TAGs) upon fish oil intake were shown to be driven by a reduction in a specific subset of the measured TAGs. This remodelling of triglycerides may represent further beneficial effects of fish oil supplementation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11306-009-0161-7) contains supplementary material, which is available to authorized users.

References

  1. JAMA. 2006 Apr 5;295(13):1549-55 - PubMed
  2. Diabetes Care. 1994 Sep;17(9):961-9 - PubMed
  3. J Lipid Res. 1964 Oct;5:600-8 - PubMed
  4. Am J Clin Nutr. 2007 May;85(5):1267-74 - PubMed
  5. Int J Obes (Lond). 2006 Oct;30(10):1535-44 - PubMed
  6. PLoS One. 2008 Jul 09;3(7):e2630 - PubMed
  7. BMC Syst Biol. 2007 Feb 15;1:12 - PubMed
  8. Int J Obes Relat Metab Disord. 2004 Aug;28(8):1004-10 - PubMed
  9. JAMA. 1978 Oct 6;240(15):1607-10 - PubMed
  10. Am J Clin Nutr. 2004 Sep;80(3):768-73 - PubMed
  11. Am J Clin Nutr. 2000 Jan;71(1 Suppl):343S-8S - PubMed
  12. J Hypertens. 2001 Oct;19(10):1745-54 - PubMed
  13. Am J Epidemiol. 1990 Sep;132(3):501-13 - PubMed
  14. N Engl J Med. 1990 Mar 29;322(13):882-9 - PubMed
  15. PLoS Genet. 2007 Apr 27;3(4):e64 - PubMed
  16. Can J Biochem Physiol. 1959 Aug;37(8):911-7 - PubMed
  17. N Engl J Med. 2001 May 3;344(18):1343-50 - PubMed
  18. Lipids. 1996 Mar;31(3):243-52 - PubMed
  19. N Engl J Med. 1995 Sep 14;333(11):677-85 - PubMed
  20. J Pediatr. 2003 Oct;143(4 Suppl):S1-8 - PubMed
  21. Annu Rev Plant Biol. 2003;54:669-89 - PubMed
  22. Philos Trans R Soc Lond B Biol Sci. 2004 Jun 29;359(1446):857-71 - PubMed
  23. J Biol Chem. 1957 May;226(1):497-509 - PubMed
  24. N Engl J Med. 2002 Feb 7;346(6):393-403 - PubMed

Publication Types

Grant support